Table 3.
Risk factors for AE by logistic regression analysis in patients with IPF.
| Clinical Variables | Univariate Logistic Analysis | Multivariate Logistic Analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95.0% CI | p-value | HR | 95.0% CI | p-value | |
| Prior corticosteroid use | 3.673 | 1.605-8.404 | 0.002 | 5.236 | 0.799-34.326 | 0.084 |
| PaO2/FiO2 (<300) | 0.011 | 0.003-0.043 | <0.001 | 0.021 | 0.004-0.106 | <0.001 |
| GAP stage (I/II/III) | 5.227 | 1.771-15.422 | 0.003 | 2.435 | 0.798-7.542 | 0.117 |
| Serum GDF-15 (>989.3 pg/ml) | 0.246 | 0.110-0.553 | 0.001 | 0.148 | 0.024-0.914 | 0.040 |